Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes

Human Molecular Genetics
Nicholas J BrayMichael C O'Donovan

Abstract

The epsilon4 haplotype of APOE is the only undisputed genetic risk factor for late-onset Alzheimer's disease (LOAD). It has been proposed that at least two other polymorphisms in the promoter of the APOE gene (-219G>T and -491A>T) might also contribute to disease susceptibility, and modulate the impact of structural changes in the ApoE protein, by altering its expression. In order to assess the extent of cis-acting influences on APOE expression in human brain, highly quantitative measures of allele discrimination were applied to cortical RNA from individuals heterozygous for the epsilon alleles. A small, but significant, increase in the expression of epsilon4 allele was observed relative to that of the epsilon3 and epsilon2 alleles (P<0.0001). Similar differences were observed in brain tissue from confirmed LOAD subjects, and between cortical regions BA10 (frontopolar) and BA20 (inferior temporal). Stratification of epsilon4/epsilon3 allelic expression ratios according to heterozygosity for the -219G>T promoter polymorphism revealed significantly lower relative expression of haplotypes containing the -219T allele (P=0.02). Our data indicate that, in human brain, most of the cis-acting variance in APOE expression is accounted fo...Continue Reading

References

Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Jul 1, 1996·Annals of Neurology·B T HymanR Wallace
Nov 5, 1997·Human Molecular Genetics·J C LambertM C Chartier-Harlin
Apr 18, 1998·Human Molecular Genetics·J C LambertM C Chartier-Harlin
Mar 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·D M HoltzmanS M Paul
May 9, 2000·Human Heredity·J H ZhaoP C Sham
Feb 15, 2001·Dementia and Geriatric Cognitive Disorders·K YamagataK Nakashima
Jul 10, 2002·Neurology·J-C LambertM-C Chartier-Harlin
Aug 17, 2002·Science·Hai YanKenneth W Kinzler
Jun 13, 2003·American Journal of Human Genetics·Nicholas J BrayMichael C O'Donovan

❮ Previous
Next ❯

Citations

Jan 29, 2009·European Journal of Human Genetics : EJHG·Alessandra BizzarroCarlo Masullo
Nov 10, 2012·Nature Biotechnology·Lucas D Ward, Manolis Kellis
Nov 6, 2007·Nature Genetics·Amanda J MyersJohn Hardy
Jul 31, 2013·Human Molecular Genetics·Chang-En YuLynn M Bekris
Dec 17, 2011·Journal of Neuroinflammation·Ling LiuSteven W Barger
Apr 14, 2007·Molecular Neurodegeneration·Suzanne E WahrleDavid M Holtzman
Jul 17, 2008·PloS One·Sun-Chong WangAxel Schumacher
Aug 23, 2011·PloS One·Glenn A DoyleWade H Berrettini
Apr 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nga Bien-LyYadong Huang
May 25, 2005·International Journal of Experimental Pathology·Massimo Tabaton, Alessandra Piccini
Jul 20, 2011·Genetic Epidemiology·Rui Xiao, Laura J Scott
Jun 26, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Lynn M BekrisChang-En Yu
Jun 9, 2007·Neurobiology of Disease·Tara M Caffrey, Richard Wade-Martins
Mar 25, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Bruna VelasquesPedro Ribeiro
Aug 15, 2009·Neuron·Jungsu KimDavid M Holtzman
Dec 3, 2014·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Norman SalemFrederic Calon
Jun 17, 2011·Neurobiology of Aging·Afia AkramVahram Haroutunian
Jul 11, 2006·Psychiatric Genetics·Nicholas J Bray, Michael C O'Donovan
Apr 20, 2012·Critical Reviews in Toxicology·Calvin C WillhiteClifton J McLellan
Nov 7, 2006·Human Molecular Genetics·Tara M CaffreyRichard Wade-Martins
Jul 23, 2018·Molecular Neurobiology·Md Sahab UddinGhulam Md Ashraf
Feb 2, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Anthony J GriswoldJeffery M Vance
Jun 12, 2021·JAD Reports·Natalia BezuchChris Murgatroyd

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.